Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Rituximab in Low-grade Non-Hodgkin's Lymphoma
NCT00369707Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Aug 2006
- Primary completion
- May 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in B-cell non-Hodgkin lymphoma, sponsored by Northwestern University. Started Aug 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00369707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369707.